Millendo Therapeutics Inc (MLND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MLND | GOVX | KAPA | ||
Company | Millendo Therapeutics Inc | Geovax Labs | Kairos Pharma Ltd | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
Open | 16.8000 | 2.31 | 1.6900 | ||
High | 16.9500 | 2.38 | 1.7400 | ||
Low | 15.9000 | 2.19 | 1.5600 | ||
Last | 15.9000 | 2.29 | 1.5700 | ||
Change | -0.9000 | -0.03 | -0.1200 | ||
% Change | -5.36% | -1.29% | -7.10% | ||
Volume | 127,506 | 641,600 | 84,000 | ||
20-Day Average Volume | 3,166,405 | 721,215 | 92,775 | ||
Previous Close | 16.8000 | 2.32 | 1.6900 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 1.3250 | 2.47 | 1.6022 | ||
20-Day Raw Stochastic | 0.00% | 12.24% | 40.68% | ||
20-Day Relative Strength | 39.60% | 46.78% | 46.72% | ||
Weighted Alpha | -9.25 | -87.97 | N/A | ||
Today's Opinion | 88% Sell | 40% Sell | N/A | ||
Previous Opinion | 88% Sell | 40% Sell | N/A | ||
Last Month's Opinion | 88% Sell | 8% Sell | N/A | ||
Performance | |||||
5-Days | |||||
%Chg | -30.26% since 06/18/21 | -2.55% since 12/13/24 | -7.65% since 12/13/24 | ||
Low | 1.0600 on 06/25/21 | 2.17 on 12/17/24 | 1.5600 on 12/20/24 | ||
High | 1.5500 on 06/21/21 | 2.47 on 12/18/24 | 1.7800 on 12/16/24 | ||
1-Month | |||||
%Chg | -5.36% since 05/25/21 | -12.26% since 11/20/24 | +7.53% since 11/20/24 | ||
Low | 1.0600 on 06/25/21 | 2.17 on 12/17/24 | 1.3300 on 12/09/24 | ||
High | 1.5500 on 06/21/21 | 3.15 on 11/25/24 | 1.9200 on 12/13/24 | ||
3-Month | |||||
%Chg | -52.47% since 03/25/21 | -22.37% since 09/20/24 | -28.31% since 09/20/24 | ||
Low | 0.9181 on 04/21/21 | 1.75 on 11/04/24 | 1.2200 on 10/01/24 | ||
High | 2.2900 on 03/26/21 | 3.88 on 11/12/24 | 2.7500 on 11/13/24 | ||
6-Month | |||||
%Chg | -53.30% since 12/24/20 | +21.16% since 06/20/24 | N/A since 09/16/24 | ||
Low | 0.9181 on 04/21/21 | 1.60 on 08/08/24 | 1.2200 on 10/01/24 | ||
High | 2.7700 on 02/10/21 | 11.18 on 08/19/24 | 4.0000 on 09/16/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 20,186 | 21,609 | 20,170 | ||
Shares Outstanding, K | 19,043 | 9,436 | 12,847 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -36,410,000 | -25,970,000 | -1,812,000 | ||
Last Quarter Sales | 0 | 2,790,000 | 0 | ||
Last Quarter Net Income | -8,390,000 | -5,820,000 | -1,047,000 | ||
60-Month Beta | 0.48 | 3.24 | N/A | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.91 on 11/12/24 | -0.10 on 11/14/24 | ||
Latest Earnings Date | 07/02/21 | 11/12/24 | 02/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |